Keith T. Schmidt

1.3k total citations
29 papers, 675 citations indexed

About

Keith T. Schmidt is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Keith T. Schmidt has authored 29 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Keith T. Schmidt's work include Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Keith T. Schmidt is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Keith T. Schmidt collaborates with scholars based in United States, Netherlands and Taiwan. Keith T. Schmidt's co-authors include William D. Figg, Cindy H. Chau, Alwin D. R. Huitema, Douglas K. Price, Dan Xie, Xiaolan Shen, Ansuman Bagchi, Judith E. Fenyk-Melody, Patrick R. Griffin and Nancy A. Thornberry and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Keith T. Schmidt

27 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith T. Schmidt United States 13 244 204 121 120 120 29 675
Hugh Zhao United States 14 84 0.3× 206 1.0× 103 0.9× 189 1.6× 31 0.3× 18 654
Jigang Wang China 16 216 0.9× 227 1.1× 55 0.5× 222 1.9× 44 0.4× 64 770
Brittany N. Allen United States 11 235 1.0× 387 1.9× 14 0.1× 55 0.5× 95 0.8× 15 912
Qi Ma China 20 152 0.6× 415 2.0× 33 0.3× 229 1.9× 24 0.2× 96 1.0k
Wang Ling China 15 269 1.1× 473 2.3× 40 0.3× 62 0.5× 27 0.2× 32 802
Tomi Häkkinen Finland 13 198 0.8× 555 2.7× 41 0.3× 112 0.9× 61 0.5× 18 1.3k
Bijun Chen United States 14 144 0.6× 434 2.1× 22 0.2× 74 0.6× 32 0.3× 28 920
Javier E. López United States 16 46 0.2× 226 1.1× 22 0.2× 38 0.3× 36 0.3× 36 622

Countries citing papers authored by Keith T. Schmidt

Since Specialization
Citations

This map shows the geographic impact of Keith T. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith T. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith T. Schmidt more than expected).

Fields of papers citing papers by Keith T. Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith T. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith T. Schmidt. The network helps show where Keith T. Schmidt may publish in the future.

Co-authorship network of co-authors of Keith T. Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Keith T. Schmidt. A scholar is included among the top collaborators of Keith T. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith T. Schmidt. Keith T. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Keith T., Kelli M. Wilson, Crystal McKnight, et al.. (2025). Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7–Expressing CRPC Models. Cancer Research Communications. 5(8). 1396–1408.
2.
Ashe, Robynne, Kirsten Remmert, Nicole Russell, et al.. (2025). A rebrand for proteasome inhibition in solid tumors via continuous hepatic artery infusion. JCI Insight. 10(24).
3.
Jurdi, Najla El, Noa G. Holtzman, Alain Mina, et al.. (2025). A phase 2 study of single agent ibrutinib for first‐line treatment of chronic graft‐versus‐host disease: A new paradigm and lessons learned. British Journal of Haematology. 206(6). 1822–1827. 1 indexed citations
4.
Schmidt, Keith T., et al.. (2024). Phase I study of ProAgio, an αvβ3 integrin cytotoxin, in patients with previously treated advanced pancreatic cancer and other solid tumors.. Journal of Clinical Oncology. 42(16_suppl). e16336–e16336. 2 indexed citations
5.
Li, Yazhou, Kelli L. Vaughan, Yun Wang, et al.. (2024). Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders. GeroScience. 46(5). 4397–4414. 6 indexed citations
6.
Hagedorn, Jonathan M., et al.. (2024). Artificial Intelligence and Pain Medicine: An Introduction. Journal of Pain Research. Volume 17. 509–518. 15 indexed citations
7.
Peer, Cody J., Keith T. Schmidt, Oluwatobi Arisa, et al.. (2023). In Silico Re‐Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure–Response Simulation. The Journal of Clinical Pharmacology. 63(6). 672–680. 9 indexed citations
8.
Sissung, Tristan M., Keith T. Schmidt, Jonathan D. Strope, et al.. (2023). GNRH2Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy. Anticancer Research. 43(9). 4023–4030. 1 indexed citations
9.
Li, Yang, Yan Jin, Keith T. Schmidt, et al.. (2022). A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities. Pharmaceutics. 14(9). 1933–1933. 5 indexed citations
10.
Schmidt, Keith T., Cindy H. Chau, Jonathan D. Strope, et al.. (2021). Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models. Molecular Cancer Therapeutics. 20(5). 915–924. 18 indexed citations
11.
Türkbey, Barış, Billel Gasmi, Keith T. Schmidt, et al.. (2021). Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers. Scientific Reports. 11(1). 5662–5662. 2 indexed citations
12.
Madan, Ravi A., Keith T. Schmidt, Fatima Karzai, et al.. (2020). Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment. Clinical Genitourinary Cancer. 18(4). 258–267.e1. 14 indexed citations
13.
Schmidt, Keith T., Alwin D. R. Huitema, Thomas P. C. Dorlo, et al.. (2020). Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 86(4). 475–486. 12 indexed citations
14.
Schmidt, Keith T., Cody J. Peer, Alwin D. R. Huitema, et al.. (2019). Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 181. 113073–113073. 16 indexed citations
15.
Peer, Cody J., Keith T. Schmidt, Joel R. Eisner, et al.. (2019). A population pharmacokinetic analysis of the oral CYP17 lyase and androgen receptor inhibitor seviteronel in patients with advanced/metastatic castration-resistant prostate cancer or breast cancer. Cancer Chemotherapy and Pharmacology. 84(4). 759–770. 3 indexed citations
16.
Sissung, Tristan M., Keith T. Schmidt, & William D. Figg. (2019). Insulin potentiation therapy for cancer?. The Lancet Oncology. 20(2). 191–192. 2 indexed citations
17.
Karakunnel, Joyson, Nam Q. Bui, Latha Palaniappan, et al.. (2018). Reviewing the role of healthy volunteer studies in drug development. Journal of Translational Medicine. 16(1). 336–336. 30 indexed citations
18.
Sikora, Andrea, Brian Murray, Samuel Jones, et al.. (2017). Effect of inhaled iloprost on gas exchange in inhalation injury. Burns Open. 1(2). 49–53. 1 indexed citations
19.
Schmidt, Keith T., Cindy H. Chau, Douglas K. Price, & William D. Figg. (2016). Precision Oncology Medicine: The Clinical Relevance of Patient‐Specific Biomarkers Used to Optimize Cancer Treatment. The Journal of Clinical Pharmacology. 56(12). 1484–1499. 85 indexed citations
20.
Zhu, Lan, Constantin Tamvakopoulos, Dan Xie, et al.. (2003). The Role of Dipeptidyl Peptidase IV in the Cleavage of Glucagon Family Peptides. Journal of Biological Chemistry. 278(25). 22418–22423. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugh Zhao Breakdown of academic impact, for papers by Jigang Wang Breakdown of academic impact, for papers by Brittany N. Allen Breakdown of academic impact, for papers by Qi Ma Breakdown of academic impact, for papers by Wang Ling Breakdown of academic impact, for papers by Tomi Häkkinen Breakdown of academic impact, for papers by Bijun Chen Breakdown of academic impact, for papers by Javier E. López
Rankless by CCL
2026